Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aya Chiyoda

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Activity Relationship Analysis of Macrocyclic Peptide RAS Inhibitors: Spotlight on the Solvent-Exposed RegionAya Chiyoda, Atsushi Matsuo, Takashi Yamano, et al.
Journal of the American Chemical Society|July 18, 2023
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS InhibitorMikimasa Tanada, Minoru Tamiya, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry|July 9, 2024
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA displayMirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Journal of the American Chemical Society|October 24, 2023
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough TargetsAtsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Medicinal Chemistry Letters|June 17, 2026
Structure-Activity Relationship Analysis of Macrocyclic Peptide RAS Inhibitors: Spotlight on the Solvent-Exposed RegionAya Chiyoda, Atsushi Matsuo, Takashi Yamano, et al.
Journal of the American Chemical Society|July 18, 2023
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS InhibitorMikimasa Tanada, Minoru Tamiya, Atsushi Matsuo, et al.
Bioorganic & Medicinal Chemistry|July 9, 2024
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA displayMirai Kage, Ryuji Hayashi, Atsushi Matsuo, et al.
Journal of the American Chemical Society|October 24, 2023
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough TargetsAtsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.
Pageof 1